0001567619-20-014357.txt : 20200805
0001567619-20-014357.hdr.sgml : 20200805
20200805185607
ACCESSION NUMBER: 0001567619-20-014357
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200803
FILED AS OF DATE: 20200805
DATE AS OF CHANGE: 20200805
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GREY MICHAEL G
CENTRAL INDEX KEY: 0001240122
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 201079154
MAIL ADDRESS:
STREET 1: C/O SGX PHARMACEUTICALS, INC.
STREET 2: 10505 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc1.xml
FORM 4
X0306
4
2020-08-03
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001240122
GREY MICHAEL G
C/O BIOMARIN PHARMACEUTICAL INC.
105 DIGITAL DRIVE
NOVATO
CA
94949
1
0
0
0
Common Stock
2020-08-03
4
M
0
2500
26.49
A
45340
D
Common Stock
2020-08-03
4
S
0
2500
120.35
D
42840
D
Stock Option (Right to buy Common Stock)
26.49
2020-08-03
4
M
0
2500
0
D
2011-11-12
2021-05-11
Common Stock
2500
5000
D
Trade made pursuant to a 10b5-1 plan executed on June 12, 2020.
Reflects the number of options outstanding after the transactions from this specific stock option grant.
/s/ Eric Fleekop, Attorney-in-Fact
2020-08-05